Expert Comparison: Understanding Your Weight Loss Options
Is Mounjaro Better Than Wegovy for Prescription Weight Loss?
Rather than determining if Mounjaro is better than Wegovy, the focus should be on which prescription weight loss treatment aligns with your individual health profile and lifestyle needs. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. Both are prescription-only medicines that require clinical assessment and ongoing monitoring. Your prescriber will consider factors including your medical history, current medications, and weight loss goals when recommending between these two evidence-based treatments. The question isn't whether Mounjaro is better than Wegovy universally, but which offers the most suitable profile for your specific circumstances.
The choice between these treatments involves understanding their distinct mechanisms and practical considerations. Wegovy follows a well-established dose escalation from 0.25mg to 2.4mg maintenance over 16 weeks, with extensive clinical data from the STEP trial programme. Mounjaro offers a different pathway through its dual incretin approach, potentially providing alternative benefits for certain patients. Both treatments are available through EverydayMeds with comprehensive prescriber support to help navigate this important decision. When considering if Mounjaro is better than Wegovy, remember that effectiveness depends on individual response, tolerability, and adherence to the prescribed regimen alongside lifestyle modifications.
Wegovy Pricing and Value: Transparent UK Costs
Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose after applying discount code FIRST40 for new customers. The complete dose escalation includes £79.99 for 0.25mg (weeks 1-4), £94.99 for 0.5mg (weeks 5-8), £99.99 for 1mg (weeks 9-12), £139.99 for 1.7mg (weeks 13-16), and £209.99 for 2.4mg maintenance dose from week 17 onwards. Our convenient bundle options include the Intro Duo (0.25mg and 0.5mg) for £169.99, providing your first two months of treatment in one order. Returning customers benefit from discount code DOSE25 applied at checkout, ensuring ongoing value throughout your weight management journey.
Our bundle pricing offers practical advantages for maintaining consistent treatment without the need for frequent reorders. The Progress Trio (0.5mg, 1mg, and 1.7mg) costs £369.99, covering months two through four of your escalation schedule. For patients reaching maintenance dose, the Ultimate Stability Trio provides three months of 2.4mg supply for £649.99, ensuring uninterrupted treatment. When evaluating if Mounjaro is better than Wegovy, cost considerations play a role alongside clinical factors. EverydayMeds provides transparent pricing without hidden fees, with next-day cold-chain delivery included once your prescription is approved by our clinical team.
Clinical Evidence: Mounjaro vs Wegovy Weight Loss Data
In clinical trials, Wegovy demonstrated significant weight loss outcomes in the STEP programme, with patients achieving an average of approximately 15% body weight reduction at 68 weeks when combined with diet and exercise (Wilding et al., NEJM, 2021). The STEP 1 trial showed ~clinically studied weight loss compared to ~2.4% with placebo, whilst STEP 2 demonstrated ~clinically studied weight loss in patients with type 2 diabetes. These results represent average outcomes in controlled trial conditions and individual responses may vary.
Mounjaro's clinical data comes from the SURMOUNT trial programme, showing different weight loss percentages in its study population. However, comparing these percentages directly doesn't answer whether Mounjaro is better than Wegovy, as the trials involved different patient populations, study designs, and endpoints. Both treatments have demonstrated cardiovascular benefits, with Wegovy's SELECT trial showing a 20% reduction in major cardiovascular events. Your prescriber will consider the full clinical evidence profile when determining which treatment may be most appropriate for your individual circumstances.
How Wegovy Works: Understanding the Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a natural hormone released by your intestines after eating. This mechanism helps reduce appetite by acting on brain centres that control hunger and satiety, leading to decreased food intake and promoting feelings of fullness after smaller meals. The once-weekly injection provides sustained hormone activity, potentially reducing food cravings and supporting portion control throughout the week. Unlike rapid-acting appetite suppressants, Wegovy works gradually to reset appetite regulation, supporting sustainable weight management when combined with dietary changes and increased physical activity. The treatment affects gastric emptying, slowing the rate at which food leaves your stomach, which contributes to prolonged satiety and reduced between-meal hunger. This comprehensive approach to appetite regulation explains why Wegovy requires gradual dose escalation to optimise effectiveness whilst minimising potential side effects.
Starting Wegovy: Simple Online Assessment Process
Beginning your Wegovy treatment through EverydayMeds involves a straightforward three-minute online clinical assessment that gathers essential health information for prescriber review. Our qualified prescribers, working under GPhC registration #9012878, review your assessment within three working days (or 24 hours with express service) to determine suitability and prescribe the appropriate starting dose. Once approved, your Wegovy pen is dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. The FlexTouch pen design provides simple subcutaneous injection with clear dose indicators and safety features. You'll receive comprehensive injection guidance and ongoing support throughout your dose escalation journey, with regular check-ins to monitor progress and adjust treatment as needed.
Storage and Practical Considerations: Wegovy vs Mounjaro
Wegovy offers a significant storage advantage over Mounjaro, remaining stable at room temperature (below 30°C) for up to six weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This flexibility benefits frequent travellers or those with limited refrigeration access, reducing storage-related treatment interruptions. Before first use, Wegovy should be stored in the refrigerator at 2-8°C, and the FlexTouch pen provides precise dosing with an easy-to-read display. The pen design accommodates users with limited dexterity, featuring a large dose button and clear clicking mechanism for dose confirmation. When considering if Mounjaro is better than Wegovy, these practical factors can influence long-term adherence and treatment success. Each pen contains four doses for weekly administration, with clear expiry dating and temperature indicators to ensure medication safety throughout your treatment course.
Personalised Treatment Selection: Beyond Mounjaro vs Wegovy Comparisons
The question of whether Mounjaro is better than Wegovy extends beyond simple efficacy comparisons to encompass personalised medicine approaches. Individual factors including metabolic profile, previous weight loss attempts, concurrent medical conditions, and medication tolerability all influence treatment selection. Some patients may respond better to Wegovy's established GLP-1 pathway, whilst others might benefit from Mounjaro's dual incretin mechanism. Your prescriber considers genetic factors, lifestyle demands, and treatment goals when making recommendations.
Rather than seeking a universal answer to whether Mounjaro is better than Wegovy, focus on which treatment offers the most appropriate risk-benefit profile for your situation. Both medications require commitment to lifestyle modifications and ongoing medical supervision. EverydayMeds provides access to both treatments with comprehensive prescriber support to optimise your individual treatment plan. The "better" treatment is ultimately the one that you can use consistently, tolerate well, and that supports your long-term weight management goals within a comprehensive healthcare approach.
Making Your Decision: Expert Guidance and Next Steps
When determining if Mounjaro is better than Wegovy for your weight loss journey, expert prescriber guidance ensures you make an informed choice based on clinical evidence rather than marketing claims. Both treatments are available through EverydayMeds following proper clinical assessment, with transparent pricing and ongoing support throughout your treatment. New customers can apply discount code FIRST40 at checkout, whilst returning customers benefit from DOSE25 for continued savings. Our prescribers, operating under GPhC #9012878, provide personalised treatment recommendations based on your individual health profile and weight management goals. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and discover which prescription weight loss treatment offers the most suitable approach for your needs. Whether you ultimately choose Wegovy or Mounjaro, both represent evidence-based options for sustainable weight management when used alongside comprehensive lifestyle modifications.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
